Author/Authors :
Boris Bentsianov، نويسنده , , Craig Zalvan، نويسنده , , Andrew Blitzer، نويسنده ,
Abstract :
Since the introduction of botulinum toxin (BTX) as a therapeutic tool in the 1970s, the number of uses for this substance has increased exponentially. BTXʹs mechanism of action involves degrading the SNARE proteins blockading the release of acetylcholine
